Macquarie Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.4M | Buy |
948,850
+56,069
| +6% | +$2.27M | 0.05% | 484 |
|
|
2025
Q1 | $45.9M | Buy |
892,781
+76,869
| +9% | +$3.95M | 0.06% | 425 |
|
|
2024
Q4 | $45.2M | Buy |
815,912
+221,034
| +37% | +$12.2M | 0.05% | 443 |
|
|
2024
Q3 | $19.6M | Buy |
594,878
+139,887
| +31% | +$4.6M | 0.02% | 672 |
|
|
2024
Q2 | $12.4M | Buy |
454,991
+304,991
| +203% | +$8.29M | 0.01% | 767 |
|
|
2024
Q1 | $5.45M | Hold |
150,000
| – | – | 0.01% | 945 |
|
|
2023
Q4 | $3.04M | Hold |
150,000
| – | – | ﹤0.01% | 1104 |
|
|
2023
Q3 | $2.67M | Hold |
150,000
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q2 | $2.71M | Hold |
150,000
| – | – | ﹤0.01% | 1085 |
|
|
2023
Q1 | $1.89M | Sell |
150,000
-22,908
| -13% | -$288K | ﹤0.01% | 1186 |
|
|
2022
Q4 | $2.54M | Hold |
172,908
| – | – | ﹤0.01% | 1139 |
|
|
2022
Q3 | $2.96M | Hold |
172,908
| – | – | ﹤0.01% | 1113 |
|
|
2022
Q2 | $2.52M | Buy |
+172,908
| New | +$2.52M | ﹤0.01% | 1217 |
|